Skip to main content
SpringerLink
Log in

Auditory mismatch negativity deficits in long-term heavy cannabis users

  • Original Paper
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

Mismatch negativity (MMN) is an auditory event-related potential indicating auditory sensory memory and information processing. The present study tested the hypothesis that chronic cannabis use is associated with deficient MMN generation. MMN was investigated in age- and gender-matched chronic cannabis users (n = 30) and nonuser controls (n = 30). The cannabis users were divided into two groups according to duration and quantity of cannabis consumption. The MMNs resulting from a pseudorandomized sequence of 2 × 900 auditory stimuli were recorded by 32-channel EEG. The standard stimuli were 1,000 Hz, 80 dB SPL and 90 ms duration. The deviant stimuli differed in duration (50 ms) or frequency (1,200 Hz). There were no significant differences in MMN values between cannabis users and nonuser controls in both deviance conditions. With regard to subgroups, reduced amplitudes of frequency MMN at frontal electrodes were found in long-term (≥8 years of use) and heavy (≥15 joints/week) users compared to short-term and light users. The results indicate that chronic cannabis use may cause a specific impairment of auditory information processing. In particular, duration and quantity of cannabis use could be identified as important factors of deficient MMN generation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Association American Psychiatric (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC

    Google Scholar 

  2. Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL (2002) Dose-related neurocognitive effects of marijuana use. Neurology 59:1337–1343

    CAS  PubMed  Google Scholar 

  3. Brown J, Kranzler HR, Del Boca FK (1992) Self-reports by alcohol and drug abuse inpatients: factors affecting reliability and validity. Br J Addict 87:1013–1024

    Article  CAS  PubMed  Google Scholar 

  4. D’Souza DC (2007) Cannabinoids and psychosis. Int Rev Neurobiol 78:289–326

    Article  PubMed  Google Scholar 

  5. D’Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper TB, Krystal JH (2005) Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry 57:594–608

    Article  PubMed  Google Scholar 

  6. D’Souza DC, Sewell RA, Ranganathan M (2009) Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci 259:413–431

    Article  PubMed  Google Scholar 

  7. ElSohly MA, Slade D (2005) Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci 78:539–548

    Article  CAS  PubMed  Google Scholar 

  8. Emrich HM, Leweke FM, Schneider U (1997) Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav 56:803–807

    Article  CAS  PubMed  Google Scholar 

  9. Gaoni Y, Mechoulam R (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86:1646–1647

    Article  CAS  Google Scholar 

  10. Hall W, Degenhardt L (2000) Cannabis use and psychosis: a review of clinical and epidemiological evidence. Aust N Z J Psychiatry 34:26–34

    Article  CAS  PubMed  Google Scholar 

  11. Harrison ER, Haaga J, Richards T (1993) Self reported drug use data: what do they reveal? Am J Drug Alcohol Abuse 19:423–441

    Article  CAS  PubMed  Google Scholar 

  12. Heekeren K, Daumann J, Neukirch A, Stock C, Kawohl W, Norra C, Waberski TD, Gouzoulis-Mayfrank E (2008) Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. Psychopharmacology 199:77–88

    Article  CAS  PubMed  Google Scholar 

  13. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932–1936

    Article  CAS  PubMed  Google Scholar 

  14. Javitt DC, Doneshka P, Grochowski S, Ritter W (1995) Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia. Arch Gen Psychiatry 52:550–558

    CAS  PubMed  Google Scholar 

  15. Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC (1996) Role of cortical N-methyl-d-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci USA 93:11962–11967

    Article  CAS  PubMed  Google Scholar 

  16. Juckel G, Roser P, Nadulski T, Gallinat J, Stadelmann AM (2007) Acute effects of delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity. Schizophr Res 97:109–117

    Article  PubMed  Google Scholar 

  17. Kempel P, Lampe K, Parnefjord R, Hennig J, Kunert HJ (2003) Auditory-evoked potentials and selective attention: different ways of information processing in cannabis users and controls. Neuropsychobiology 48:95–101

    Article  CAS  PubMed  Google Scholar 

  18. Lepistö T, Silokallio S, Nieminen-von Wendt T, Alku P, Näätänen R, Kujala T (2006) Auditory perception and attention as reflected by the brain event-related potentials in children with Asperger syndrome. Clin Neurophysiol 117:2161–2171

    Article  PubMed  Google Scholar 

  19. Lundqvist T (2005) Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav 81:319–330

    Article  CAS  PubMed  Google Scholar 

  20. Lundqvist T, Jönsson S, Warkentin S (2001) Frontal lobe dysfunction in long-term cannabis users. Neurotoxicol Teratol 23:437–443

    Article  CAS  PubMed  Google Scholar 

  21. McPartland JM (2008) Adulteration of cannabis with tobacco, calamus, and other cholinergic compounds. Cannabinoids 3:16–20

    Google Scholar 

  22. Mechoulam R, Parker LA, Gallily R (2002) Cannabidiol: an overview of some pharmacological aspects. J Clin Pharmacol 42(Suppl 11):11S–19S

    CAS  PubMed  Google Scholar 

  23. Näätänen R (1995) The mismatch negativity: a powerful tool for cognitive neuroscience. Ear Hear 16:6–18

    Article  PubMed  Google Scholar 

  24. Näätänen R, Alho K (1995) Generators of electrical and magnetic mismatch responses in humans. Brain Topogr 7:315–320

    Article  PubMed  Google Scholar 

  25. Näätänen R, Michie PT (1979) Early selective-attention effects on the evoked potential: a critical review and reinterpretation. Biol Psychol 8:81–136

    Article  PubMed  Google Scholar 

  26. Näätänen R, Paavilainen P, Tiitinen H, Jiang D, Alho K (1993) Attention and mismatch negativity. Psychophysiology 30:436–450

    Article  PubMed  Google Scholar 

  27. Noland JS, Singer LT, Short EJ, Minnes S, Arendt RE, Kirchner HL, Bearer C (2005) Prenatal drug exposure and selective attention in preschoolers. Neurotoxicol Teratol 27:429–438

    Article  CAS  PubMed  Google Scholar 

  28. Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97–113

    Article  CAS  PubMed  Google Scholar 

  29. Quickfall J, Crockford D (2006) Brain neuroimaging in cannabis use: a review. J Neuropsychiatry Clin Neurosci 18:318–332

    PubMed  Google Scholar 

  30. Pekkonen E (2000) Mismatch negativity in aging and in Alzheimer’s and Parkinson’s diseases. Audiol Neurootol 5:216–224

    Article  CAS  PubMed  Google Scholar 

  31. Potvin S, Joyal CC, Pelletier J, Stip E (2008) Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis. Schizophr Res 100:242–251

    Article  PubMed  Google Scholar 

  32. Ritter W, Deacon D, Gomes H, Javitt DC, Vaughan HG Jr (1995) The mismatch negativity of event-related potentials as a probe of transient auditory memory: a review. Ear Hear 16:52–67

    Article  CAS  PubMed  Google Scholar 

  33. Rodriguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M (2005) The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol 40:2–14

    CAS  PubMed  Google Scholar 

  34. Roser P, Vollenweider FX, Kawohl W (2008) Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists. World J Biol Psychiatry. 7:1–12. doi:10.1080/15622970801908047

    Google Scholar 

  35. Roser P, Stadelmann AM, Arning L, Gallinat J, Epplen JT, Juckel G (2008) Acute effects of Δ9-tetrahydrocannabinol on the auditory event-related mismatch negativity depending on genetic variations in the dysbindin, neuregulin and G72 gene. Int J Neuropsychopharmacol 11(Suppl 1):256

    Google Scholar 

  36. Sarne Y, Mechoulam R (2005) Cannabinoids: between neuroprotection and neurotoxicity. Curr Drug Targets CNS Neurol Disord 4:677–684

    Article  CAS  PubMed  Google Scholar 

  37. Scallet AC (1991) Neurotoxicology of cannabis and THC: a review of chronic exposure studies in animals. Pharmacol Biochem Behav 40:671–676

    Article  CAS  PubMed  Google Scholar 

  38. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33

    Google Scholar 

  39. Shelley AM, Ward PB, Catts SV, Michie PT, Andrews S, McConaghy N (1991) Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biol Psychiatry 30:1059–1062

    Article  CAS  PubMed  Google Scholar 

  40. Solowij N (1998) Cannabis and cognitive functioning. Cambridge University Press, Cambridge

    Book  Google Scholar 

  41. Solowij N, Michie PT, Fox AM (1991) Effects of long-term cannabis use on selective attention: an event-related potential study. Pharmacol Biochem Behav 40:683–688

    Article  CAS  PubMed  Google Scholar 

  42. Solowij N, Michie PT, Fox AM (1995) Differential impairment of selective attention due to frequency and duration of cannabis use. Biol Psychiatry 37:731–739

    Article  CAS  PubMed  Google Scholar 

  43. Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, Christiansen K, McRee B, Vendetti J (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 287:1123–1131

    Article  PubMed  Google Scholar 

  44. Sussman E, Ritter W, Vaughan HG Jr (1998) Attention affects the organization of auditory input associated with the mismatch negativity system. Brain Res 789:130–138

    Article  CAS  PubMed  Google Scholar 

  45. Umbricht D, Krljes S (2005) Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res 76:1–23

    Article  PubMed  Google Scholar 

  46. Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC (2000) Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 57:1139–1147

    Article  CAS  PubMed  Google Scholar 

  47. Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I (2007) Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci 80:1415–1419

    Article  CAS  PubMed  Google Scholar 

  48. Wobrock T, Sittinger H, Behrendt B, D’Amelio R, Falkai P, Caspari D (2007) Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 257:203–210

    Article  PubMed  Google Scholar 

  49. Wobrock T, Sittinger H, Behrendt B, D’Amelio R, Falkai P (2009) Comorbid substance abuse and brain morphology in recent-onset psychosis. Eur Arch Psychiatry Clin Neurosci 259:28–36

    Article  PubMed  Google Scholar 

  50. Woldorff MG, Hillyard SA, Gallen CC, Hampson SR, Bloom FE (1998) Magnetoencephalographic recordings demonstrate attentional modulation of mismatch-related neural activity in human auditory cortex. Psychophysiology 35:283–292

    Article  CAS  PubMed  Google Scholar 

  51. Yücel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, Lubman DI (2008) Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry 65:694–701

    Article  PubMed  Google Scholar 

  52. Zuardi AW, Crippa JAS, Hallak JEC, Moreira FA, Guimarães FS (2006) Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res 39:421–429

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

The authors declare that they have no potential conflicts of interest in the context of the subject of this article.

Author information

Authors and Affiliations

  1. Department of Psychiatry, Ruhr-University Bochum, Alexandrinenstr. 1, 44791, Bochum, Germany

    Patrik Roser, Beate Della, Christine Norra, Idun Uhl, Martin Brüne & Georg Juckel

Authors
  1. Patrik Roser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beate Della
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christine Norra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Idun Uhl
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Martin Brüne
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Georg Juckel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrik Roser.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roser, P., Della, B., Norra, C. et al. Auditory mismatch negativity deficits in long-term heavy cannabis users. Eur Arch Psychiatry Clin Neurosci 260, 491–498 (2010). https://doi.org/10.1007/s00406-010-0097-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-010-0097-y

Keywords

Search

Navigation